Quitine Nicotine Lozenge
Product Images NDC 84720-007

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Quitine Nicotine (NDC 84720-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quitine Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

74m-qe-nicotine-lozenges.jpg (74m Qe Nicotine Lozenges)

74m-qe-nicotine-lozenges.jpg (74m Qe Nicotine Lozenges)
This text appears to be a description of a sugar-free nicotine lozenge intended to aid in smoking cessation. The product is Nicotine Polacrilex Lozenge with 4 mg of nicotine. It features an QR code for more information and guidance on quitting smoking. The text mentions it is for those who want to quit smoking and includes a Nicotine Polacrilex Lozenge as a stop-smoking aid. The product seems to be for individuals who are serious about quitting smoking and are committed to their quitting journey.*
FDA Label Image

Wallet Card 1-image (Image 01)

Wallet Card 1-image (Image 01)
This text provides a list of phone numbers for different organizations where one can seek help. The numbers include those for the American Lung Association, American Cancer Society, and American Heart Association. Additionally, it suggests reaching out to a "Quitting Buddy" or a friend who has successfully quit a certain habit or addiction for support.*
FDA Label Image

Wallet Card 2-image (Image 02)

FDA Label Image

Smoke Free Habits-image (Image 03)

FDA Label Image

Upc-image (Image 04)

FDA Label Image

Reminder Sticker-image (Image 05)

Reminder Sticker-image (Image 05)
This text appears to be about a quit smoking program that involves taking lozenges every few hours. The program spans over a period of at least 12 weeks, with specific instructions provided for the first week and 10th week after quitting. The suggested frequency for taking the lozenges seems to vary between 1 every few hours to 1 every 4 to 8 hours.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.